, in Older Patients With Heart Failure and Left Ventricular Systolic Dysfunction National Patterns of Use and Effectiveness of Angiotensin-Converting Enzyme Inhibitors
暂无分享,去创建一个
H. Krumholz | S. Rathore | J. Curtis | Yongfei Wang | J. Foody | F. Masoudi | E. Havranek
[1] Harlan M Krumholz,et al. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. , 2003, American heart journal.
[2] Paul G Shekelle,et al. Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. , 2003, Journal of the American College of Cardiology.
[3] S. Jencks,et al. Change in the quality of care delivered to Medicare beneficiaries, 1998-1999 to 2000-2001. , 2003, JAMA.
[4] Harlan M Krumholz,et al. Representation of the elderly, women, and minorities in heart failure clinical trials. , 2002, Archives of internal medicine.
[5] H. Krumholz,et al. Spectrum of heart failure in older patients: results from the National Heart Failure project. , 2002, American heart journal.
[6] E. Antman,et al. ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary , 2002 .
[7] M. Domanski,et al. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. , 2001, The New England journal of medicine.
[8] Salim Yusuf,et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients , 2000, The Lancet.
[9] I. Piña,et al. Evaluating quality of care for patients with heart failure. , 2000, Circulation.
[10] J. Zhang,et al. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. , 1998, JAMA.
[11] K. Parker,et al. Determinants of mortality in elderly patients with heart failure: the role of angiotensin-converting enzyme inhibitors. , 1998, Archives of internal medicine.
[12] H. Krumholz,et al. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. , 1998, JAMA.
[13] B. Psaty,et al. Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995. , 1998, Archives of internal medicine.
[14] J. P. Araújo,et al. Angiotensin-converting enzyme inhibitors in heart failure: physicians' prescribing behavior. , 1997, Journal of cardiac failure.
[15] A. Cowley,et al. Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners? , 1997, International journal of cardiology.
[16] M. Malone. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. The Large State Peer Review Organization Consortium. , 1997, Archives of internal medicine.
[17] K. Kenward. The scope of the data available in the AMA's Physician Masterfile. , 1996, American journal of public health.
[18] H. Krumholz,et al. Aspirin in the treatment of acute myocardial infarction in elderly Medicare beneficiaries. Patterns of use and outcomes. , 1995, Circulation.
[19] E. Fisher,et al. Studying Outcomes and Hospital Utilization in the Elderly: The Advantages of a Merged Data Base for Medicare and Veterans Affairs Hospitals , 1992, Medical care.
[20] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.